Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Hemato-Oncology Testing Market will value USD 8.56 billion by 2030 : GreyViews

Published

on

<!– Name:DistributionId Value:8738296 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:5557 –> <!– Name:CustomerId Value:1257299 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:b90781e2-f73e-495e-8b52-f3b49159983a –>

Pune India, Jan. 28, 2023 (GLOBE NEWSWIRE) — The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the hemato-oncology testing market is operating and is predicted to expand soon. The manufacturers and suppliers involved in the hemato-oncology testing market are present across various countries in the above-mentioned regions.

Get Sample Copy of This Report @ https://greyviews.com/reports/hemato-oncology-testing-market/458/request-sample

The report provides a detailed understanding of the market segments which have been formed by combining different prospects such as cancer type, product, technology, end-user,  and regions. The key driving factors, restraints, potential growth opportunities and market challenges are also discussed in the paragraphs below.
The significant players operating in the global hemato-oncology testing market are F. Hoffman-La Roche Ltd, Thermo Fisher Scientific, Inc., EntroGen, Inc., Abbott Laboratories, Qiagen N.V., Cepheid, Bio-Rad Laboratories, Inc, Illumina, Inc. among others. To achieve a substantial market share in the worldwide hemato-oncology testing market and strengthen their position, manufacturers are pursuing expansion methods such as current developments, mergers and acquisitions, product innovations, collaborations, and partnerships, joint ventures.
The purpose of hemato oncology testing is to diagnose, treat, and study blood cell, bone marrow, and related tissue cancers. These tests are used to diagnose diseases like sickle cell disease, haemophilia, thalassemia, iron deficiencies, leukemia, and other organ cancers. Sales of assay kits and reagents are driven by the demand for drug discoveries, biotechnology research, and the prevalence of infectious diseases. Assay kits reduce ambiguity by providing accurate diagnostic results, which is boosting sales of market. Another major factor contributing to the growth of the market for hemato oncology testing is the availability of advanced molecular techniques for the diagnosis of hemato oncology. The introduction of advanced molecular techniques has been critical in addressing concerns pertaining to blood cancer prognosis, treatment course, and diagnosis. The government, however, has imposed strict rules and is delaying clearance of experimental molecular diagnostic tests, which may adversely affect market growth during the forecast period. Furthermore, in the near future, artificial intelligence (AI) may become more prevalent in cancer diagnosis, resulting in faster market growth. A number of cancer types are being screened using artificial intelligence. AI-based computer algorithms have helped clinicians interpret mammograms for more than 20 years, and this field is rapidly developing and will create more growth opportunities for the market.

Enquiry Before Buying This Report @ https://greyviews.com/inquiry/458

Advertisement
Stake.com

Scope of Hemato-Oncology Testing Market Report:

Report Metric Information
Study Period 2022-2030
Base Year              2022
Forecast Period 2023-2030
Market Share Unit USD Billion
Segments Covered Cancer Type, Product, Technology, End-User, and Regions.
Regions Covered North America, Europe, Asia-Pacific, South America, and Middle-East and Africa
Major Players F. Hoffman-La Roche Ltd, Thermo Fisher Scientific, Inc., EntroGen, Inc., Abbott Laboratories, Qiagen N.V., Cepheid, Bio-Rad Laboratories, Inc, Illumina, Inc. among others

Segmentation Analysis

Lymphoma is expected to be the fastest-growing segment in 2022. 

The cancer type segment includes myeloproliferative neoplasms, leukemia, lymphoma, and others. The lymphoma segment is expected to witness the highest growth rate during the forecast period. A growing awareness of personalized medications and other treatment options is predicted to spur segment growth during the forecast period. As non-Hodgkin and Hodgkin’s lymphomas become more prevalent in the U.S, NHL accounts for 4.2% of all cancer cases. NHL is the seventh most common cancer in the U.S., according to the National Institutes of Health (NIH) in 2019.

Services are expected to be the fastest-growing segment in 2022. 

Advertisement
Stake.com

The product segment is services and assay kits & reagents. The services segment is expected to witness the highest growth rate during the forecast period. As a result of increasing awareness of advanced therapies such as personalized medicine and the rise in leukemia and myeloma cancers, the services segment is expected to dominate the global hemato-oncology test market over the forecast period. The segment is also growing as awareness of advanced treatment therapies such as personalized medicine becomes more prevalent.

Services are expected to be the fastest-growing segment in 2022. 

The technology segment is Cytogenetics, PCR, NGS, IHC, and Others. The PCR segment is expected to witness the highest growth rate during the forecast period. This is due to the fact that it is easy to use, affordable, provides accuracy and efficiency, and is widely accessible. The Diagnostic Laboratories of the BloodCenter of Wisconsin debuted the Abbott RealTime IDH1 assay in July 2018. This PCR test can be performed to find genetic variations in the IDH1 gene from patient bone marrow and blood samples. As a result, it is predicted that an increase in the quantity of PCR-based test launches will promote market expansion at the period of forecasting. In a similar vein, Cepheid’s Xpert BCR-ABL Ultra received FDA approval in October 2019 to monitor a person’s risk of developing chronic myeloid leukaemia. With the use of this in-vitro diagnostic process, complete blood samples taken within three hours might yield precise results.

Services are expected to be the fastest-growing segment in 2022. 

The end-user segment is Academic & Research Institutes, Hospitals, and Others. The hospitals segment is expected to witness the highest growth rate during the forecast period. The availability of specialised laboratory settings, the rise in the incidence rate of blood cancers, the wide range of diagnostic tests available, and the prevalence of healthcare professionals who can conduct diagnostic tests and monitor the disease are all factors contributing to the growth that has been seen.

Advertisement
Stake.com

Regional Analysis           

The regional analysis provides a detailed perception of the key regions and the countries. Some of the key countries analyzed for the hemato-oncology testing market include the US, Canada, Mexico, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Brazil, Peru, UAE, South Africa, and Saudi Arabia.

The North American region witnessed a major share. As a major revenue contributor in the region, North America is also a leading contributor globally. The large share of this segment can primarily be attributed to the high incidences of hematologic cancer, the aging population, awareness of advanced treatment methods, and strong presence of industry players in the region. During the forecast period, these trends are likely to drive market growth.

Country Analysis

Germany’s hemato-oncology testing market size was valued at USD 0.21 billion in 2022 and is expected to reach USD 0.62 billion by 2030, at a CAGR of 14.6% from 2023 to 2030.
Heavy smoking and binge drinking are most likely to contribute to the rise in cancer rates across the nation. It is significant that strong institutional frameworks, like the German Cancer Consortium and significant University Medical Center-based Comprehensive Cancer Centers, contribute to the advancement of cancer research in all parts of the country (CCCs).

Advertisement
Stake.com

China’s hemato-oncology testing market size was valued at USD 0.22 billion in 2022 and is expected to reach USD 0.66 billion by 2030, at a CAGR of 14.8% from 2023 to 2030.
There is a strong possibility that the rapid growth of medical tourism in the country will lead to a greater demand for cancer treatment and diagnostic procedures. Furthermore, the rise in cancer cases is encouraging hemato-oncology testing, which is boosting the market growth.

India’s hemato-oncology testing market size was valued at USD 0.17 billion in 2022 and is expected to reach USD 0.50 billion by 2030, at a CAGR of 14.7% from 2023 to 2030.
There is a growing prevalence of blood cancer, and a growing number of academic research institutes actively conducting research. This is expected to lead to the highest growth rate in the market.
Covid-19 Impact
Covid-19 had a major impact on almost all industries, such as electronics, semiconductors, manufacturing, automobile, etc. However, several companies operating in the technology sector have seen increased revenue due to significant changes in consumer preferences toward technological services. In addition, the pandemic has led to significant growth in technology across developing and developed countries.

Furthermore, the growth of this market is mainly driven owing to the rising cases of cancer.

Buy Now Full Report @ https://greyviews.com/checkout/458/single_user_license

Contact Us
Rocky Shah
GreyViews
Pune India
Phone: (+44) 162-237-1047
Email: [email protected]

Advertisement
Stake.com

Web: https://greyviews.com/

Follow Us: LinkedIn | Twitter

Browse Related Reports:

Biomedical Sensors Market Size By Type (Wired and Wireless), By Sensor Type (Biochemical Image Sensors, Temperature, Pressure, and Others), By Industry (Pharmaceutical, Healthcare, and Others), Regions, Segmentation, and Projection till 2030      

https://greyviews.com/reports/biomedical-sensors-market/475

Advertisement
Stake.com

Veterinary Hematology Analyzers Market Size By Product Type (Table Top Analyzers (Fully Automatic Analyzers and Semiautomatic Analyzers) and Point of Care Analyzers (Cartridge-Based Analyzers and Direct Sample Based Analyzers), By Analysis Parameter (2-Part WBC Differential, 3-Part WBC Differential, 5-Part WBC Differential, and Others), By End-User (Research institutes, Veterinary hospitals and clinics, Veterinary diagnostic centers, point-of-care testing, inhouse-testing, and others), Regions, Segmentation, and Projection till 2030

https://greyviews.com/reports/veterinary-hematology-analyzers-market/469

Structural Heart Devices Market Size By Indication (Atrial Septal Defects, Aortic Valvular Disease, Pulmonary Valvular Disease, Patent Foramen Ovale, Ventricular Septal Defects, Mitral Valvular Disease, Patent Ductus Arteriosus, and Others), By Product Type (Heart Valve Devices, Annuloplasty Rings, Occluders and Delivery Systems, Transcatheter Mitral Valve Repair, and Others), By Procedure(Repair and Replacements), Regions, Segmentation, and Projection till 2030          

https://greyviews.com/reports/structural-heart-devices-market/467

Shoulder Arthroplasty Market Size By Indication (Arthritis, Fracture/Dislocation, Rotator Cuff Tear Arthropathy, Hill Sachs Defect, and Others), By Device (Shoulder Arthroplasty Resurfacing Implants, Shoulder Arthroplasty Trauma Devices, and Shoulder Arthroplasty Platform Systems), By Procedure (Partial Shoulder Arthroplasty, Total Shoulder Arthroplasty, Reverse Shoulder Arthroplasty, and Revision Shoulder Arthroplasty), Regions, Segmentation, and Projection till 2030  

Advertisement
Stake.com

https://greyviews.com/reports/shoulder-arthroplasty-market/466

Radiopharmaceuticals Market Size By Procedural Volume (Diagnostic Producers and Therapeutic Procedures), By Application (Endocrinology, Oncology, Neurology, Cardiology, and Others), Regions, Segmentation, and Projection till 2030     

https://greyviews.com/reports/radiopharmaceuticals-market/465

Intrathecal Pumps Market Size By Type (Morphine, Baclofen, Ziconotide, Clonidine, Bupivacaine, and Others), By Application (Pain and Spasticity), Regions, Segmentation, and Projection till 2030   

https://greyviews.com/reports/intrathecal-pumps-market/462

Advertisement
Stake.com

Injection Molding Market Size By Material (Metals, Plastics, and Others), By Technology (Electric, Hydraulic, and Hybrid), By Application (Building & Construction, Packaging, Medical, Consumables & Electronics, Automotive & Transportation, and Others), Regions, Segmentation, and Projection till 2030   

https://greyviews.com/reports/injection-molding-market/461

Influenza Diagnostics Market Size By Test Type (Cell Culture, RIDT, RT-PCR and Others), By End-User (Diagnostic Laboratories, Clinics, Hospitals and Others), Regions, Segmentation, and Projection till 2030          

https://greyviews.com/reports/influenza-diagnostics-market/460

Intrathecal Pumps Market Size By Type (Morphine, Baclofen, Ziconotide, Clonidine, Bupivacaine, and Others), By Application (Pain and Spasticity), Regions, Segmentation, and Projection till 2030   

Advertisement
Stake.com

https://greyviews.com/reports/hemato-oncology-testing-market/458

Embolotherapy Market Size By Disease (Oncology, Peripheral Vascular Diseases and Others), By Embolic Agents (Liquid Embolic Agent, Microspheres, Embolic Coils, Detachable Balloons and Others), By End-User (Ambulatory Surgery Centres, Hospitals & Clinics and Others), Regions, Segmentation, and Projection till 2030          

https://greyviews.com/reports/embolotherapy-market/453

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

AddSecure to provide proactive fleet technology to avoid DVS consequences

Published

on

addsecure-to-provide-proactive-fleet-technology-to-avoid-dvs-consequences

NORTHAMPTON, England, May 29, 2024 /PRNewswire/ — AddSecure will deploy its latest PSS solution across NE Transport Solutions’ vehicles, ensuring DVS compliance and preventing potential fines.

Leading European provider of secure IoT connectivity and end-to-end solutions, AddSecure, has joined forces with Essex-based transport operator, NE Transport Solutions, to ensure the safety of vulnerable road users across London.
NE Transport Solutions provide general haulage across the UK, operating a fleet of 34 vehicles. The company works with major European suppliers providing last mile delivery of their goods to construction sites across London and needed to make sure every vehicle was ready for the regulation changes coming into force later this year.
Transport for London (TFL)’s Direct Vision Standard (DVS) is due to change in October 2024, meaning heavy goods vehicles (HGVs) will need to fit a Progressive Safe System (PSS) – which warns drivers of the presence of vulnerable road users in blind spots at the nearside and front of the vehicle – if falling beneath the three-star threshold.
With a market-leading PSS offering, NE Transport Solutions approached AddSecure to provide and fit their latest solution to each of its 34 vehicles, ensuring it was operating DVS-compliant fleet and avoiding potential fines.
Zoltan Serfozo, Transport Manager, NE Transport Solutions, said; “With AddSecure as our new supplier, we’re now able to install a standalone solution, that doesn’t need to be integrated with our existing telematics or vehicle cameras. We feel this minimises risk to our business as it’s efficient, effective and avoids vehicle downtime.”
Zoltan has proactively implemented AddSecure’s RoadView BSD solution into his business ahead of the October 2024 deadline, enabling NE Transport Solutions to avoid any potential distruption that might be experienced with an influx of requests nearer the time.
Ensuring the entire fleet is compliant well ahead of the deadline will mitigate any potential restrictions on vehicle entry to London – resulting in a seamless service and customer satisfaction.
Paul Lawrence, managing director at AddSecure UK, said: “The pending changes to operating fleets within the Greater London area is something every operator needs to be aware of. NE Transport Solutions have taken the step of ensuring its vehicles are DVS compliant well ahead of the October deadline.
“We are seeing an increase in businesses looking to install equipment ahead of the changes and urge any operators considering making the change to act sooner rather than later to avoid delays with installation.”
To find out more about Progressive Safe System solutions for your fleet, visit AddSecure.
For more information, please contact:Helena Ferraro, Marketing Manager, Smart Transport UK, AddSecureTel. +443301112636, [email protected] Grandin, Director Corporate Communications, AddSecure GroupMobile: +46 70 689 52 08, [email protected]
This information was brought to you by Cision http://news.cision.com.
https://news.cision.com/addsecure-group/r/addsecure-to-provide-proactive-fleet-technology-to-avoid-dvs-consequences,c3982279
The following files are available for download:
https://mb.cision.com/Main/20399/3982279/2829883.pdf
Release
https://news.cision.com/addsecure-group/i/addsecure-pss-solution,c3301029
AddSecure PSS solution
https://news.cision.com/addsecure-group/i/ne-transport-pss,c3301030
NE Transport PSS
 

View original content:https://www.prnewswire.co.uk/news-releases/addsecure-to-provide-proactive-fleet-technology-to-avoid-dvs-consequences-302157827.html

Continue Reading

Artificial Intelligence

Green Utopia made in Green Tech Valley 2024

Published

on

green-utopia-made-in-green-tech-valley-2024

GRAZ, Austria, May 29, 2024 /PRNewswire/ — When carbon busters combat toxic gases in the atmosphere, when moulded components grow directly from trees or when bacteria as “employees” in industry ensure clean production, then this is Green Utopia – made in Green Tech Valley 2024. Eight short videos show how strong research at the site is making a green future possible.

The climate crisis requires a rapid rethink and innovative solutions. In the second edition of the cross-university and cross-cluster project “Green Utopia – made in Green Tech Valley”, teams of students from local colleges and universities have once again translated current high-tech research at the location into utopian and visionary short videos. Eight utopias were presented on the big stage last week at the high-calibre award ceremony.
Why utopias? The purposeful dreaming that is made possible in this way harbours massive power for the upcoming energy, mobility and resource turnaround. The visions combine technological research and social change. They include the production of hydrogen from pollutants, the use of cyanobacteria for green materials, the suburbs as climate sponges for water and heat, nature as a legal entity, plastic-free compost, wood as a high-tech material, rails as an electric motorway and plant-based blood vessels from the printer. Today’s utopias are tomorrow’s reality
“More and more technologies based on disruptive research for a green future are coming from Europe, especially from Green Tech Valley in the south of Austria. These utopias make economic courage inwardly and excellent research outwardly internationally visible,” says Green Tech Valley Managing Director Bernhard Puttinger. The short videos were created by teams of students from FH Joanneum, TU Graz, the University of Graz and the University of Leoben together with Creative Industries and Holzcluster Steiermark. These are now being widely communicated internationally in a campaign. Eberhard Schrempf, Managing Director of Creative Industries Styria: “Utopias are the reality of tomorrow, according to the motto: We dream it, so we can do it!”
All videos, information and details on: https://www.greentech.at/en/tools/green-utopia
Statements:
Horst Bischof, Rector of Technical University Graz: “‘Sustainable Systems’ is TU Graz’s greatest area of scientific strength. Here, researchers from all disciplines and faculties work together on complex challenges and research sustainable solutions. The spectrum of research topics ranges from future-orientated urban planning, innovative building technologies and the use of renewable energy sources to intelligent energy networks and green mobility. In disciplines such as railway research, hydrogen research or sustainable energy systems, TU Graz is one of the international research leaders. A location becomes a centre of innovation when it thinks and researches across disciplines, institutions and borders and works on solutions for major social challenges. Styria is such a place, where bright minds are uninhibited and inspired to research encouraging utopias. And initiatives like Green Utopia give them the stage.”
Peter Moser, Rector of Montanuniversität Leoben: “The major challenges facing society in the areas of resource scarcity, climate, energy and the environment predominantly require the use of technical and scientific methods. The University of Leoben sees its task as making a significant contribution to overcoming these challenges through excellent research and high-quality education. One current project involves the construction of the new hydrogen centre, which will open in autumn. In future, this centre will conduct research at the highest level into the production of green hydrogen. Or in the field of recycling, where basic principles such as digital, sensor-based waste analysis and sorting technologies are being researched at a research facility. The University of Leoben has always been characterised by its networking and interdisciplinary cooperation. The Green Utopia project will further strengthen the location while benefiting the individual stakeholders. This project also offers space for visionary ideas and bold solutions.”
Martin Payer, Managing Director of FH Joanneum: “As a university of the future, FH JOANNEUM is convinced that green utopias are needed to make the future of our society worth living in. We encourage people to think ahead and conduct research into important topics such as digitalisation, health, climate change, energy and mobility. Students and lecturers at all our institutes are therefore already tackling future topics in a practical way: the Energy Lab and Mobility Lab at FH JOANNEUM in Kapfenberg are researching renewable energies and forms of mobility, among other things. Environmentally friendly aviation is the focus of the Aviation degree programme in Graz, sustainable tourism at the Institute of Health and Tourism Management at FH JOANNEUM in Bad Gleichenberg. And last but not least, our Information Design students deal with green utopias when they visualise the contents of the eight green research utopias of ‘Green Utopia’ in order to communicate them to the public.”
Peter Riedler, Rector of the University of Graz: “At the University of Graz, we provide answers to the questions of our time. For these major challenges, including digital change, social upheaval and the climate crisis, the University of Graz provides solutions and explanations that we bring to the people. For example, our researchers have achieved a breakthrough that could become a game changer for the plastics industry. Chemists have developed a fully recyclable, bio-based epoxy plastic. An innovation with major implications that combines environmental protection and economic efficiency. Scientists at the University of Graz are used to pushing the boundaries of the everyday and rethinking issues. For example, slowing down climate change requires the expertise of many disciplines: natural sciences, social sciences and law. We also cross borders in our collaboration with the universities on site: for example, with Graz University of Technology for 20 years in the NAWI Graz cooperation.”
Enquiries:Veronika Pranger | Communication Green Tech Valley | [email protected] +43 316 407744-16  bzw.  +43 676 75 08 780

View original content:https://www.prnewswire.co.uk/news-releases/green-utopia-made-in-green-tech-valley-2024-302157814.html

Continue Reading

Artificial Intelligence

IFS and PwC UK Announce Collaboration for Sustainability Management Solution

Published

on

ifs-and-pwc-uk-announce-collaboration-for-sustainability-management-solution

Powerful combination of technology and services will enable decisive sustainability action for customers globally
LONDON, May 29, 2024 /PRNewswire/ — IFS, the leading technology provider of cloud and industrial AI software, and professional services firm PwC*, a recognized Global Leader in ESG and Sustainability, have announced a collaboration to bring to market a Sustainability Management Solution that will include vital technology and services to support compliance with sustainability disclosure requirements and embedding sustainable practices into business operations, including for multi-national organisations.

The initiative will see IFS develop a Sustainability Management module within IFS Cloud. PwC will contribute its expertise in Environmental, Social, and Governance (ESG) criteria and the ever-evolving regulatory landscape to assist in the design and build.
Once completed, the solution will help IFS customers navigate the new requirements of the Corporate Sustainability Reporting Directive (CSRD) and other emerging mainstream global regulatory standards that our customers are facing.
To ensure a seamless journey from start to finish, customers using IFS Cloud can enlist the services of PwC to guide on the wide range of issues facing our customers in relation to this critical aspect of governance, along with mandatory strategic ESG tasks like conducting a double materiality assessment and offering guidance for CSRD readiness.
The module will boast key features such as out-of-the-box CSRD metrics, select IFS Cloud data mapping, approval workflows, target setting, and insights. It will deliver a library of KPIs, including quantitative metrics with calculation logic, all supported by PwC’s ESG experts to ensure credibility. The tool is designed to support customers as they navigate the sustainability disclosure landscape, while helping them remain focused on delivering real business value through identifying opportunities to transition to more sustainable and productive ways of operating.
Mark Moffat, IFS CEO commented: “This strategic coalition between IFS and PwC is not just a technological advantage; it is a commitment to shaping a sustainable and transparent ecosystem. By equipping customers with the necessary tools and data, we are together enabling decisive sustainability action and ensuring we maintain the highest standards in sustainability disclosures.”
Carl Sizer, PwC UK Management Board Member and ESG Sponsor, commented: “We’re thrilled to collaborate with IFS in developing the Sustainability Management module within IFS Cloud. Our expertise in ESG criteria and knowledge of the regulatory landscape will enable us to provide valuable guidance and support in designing a solution that empowers organisations to effectively manage their sustainability initiatives and navigate the evolving regulatory landscape.”
The first version of the Sustainability Management Module is set to launch in the IFS Cloud 24R2 release at the end of November; it is currently under development and will be a cornerstone of this partnership. Alongside the IFS Cloud Sustainability Management module, PwC UK will provide the required services for companies to be compliant for their first CSRD reporting cycle in 2025.
*  Where “PwC” is referenced in this press release it relates specifically to the collaboration with IFS and PwC UK, the UK member firm, part of the PwC network. Each member firm is a separate legal entity.
CONTACT:
Contact information:EUROPE / MEA / APJ: Adam GillbeIFS, Director of Corporate & Executive CommunicationsEmail: [email protected]: +44 7775 114 856
NORTH AMERICA / LATAM: Mairi MorganIFS, Director of Corporate & Executive CommunicationsEmail: [email protected]: +44 7918 607 299
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
https://mb.cision.com/Public/855/3990490/b344aae84e3f5bb8.pdf
IFS and PwC Announce Collaboration 003 FINAL-240524
https://mb.cision.com/Public/855/3990490/80ea6d213c5295de_org.jpg
IFS Social IFS-PwC logo-lock-up 05-24 2

View original content:https://www.prnewswire.co.uk/news-releases/ifs-and-pwc-uk-announce-collaboration-for-sustainability-management-solution-302157744.html

Continue Reading
Advertisement
Stake.com
Advertisement

Latest News

Trending